Lipella Pharmaceuticals Inc.

NasdaqCM:LIPO Stock Report

Market Cap: US$5.7m

Lipella Pharmaceuticals Management

Management criteria checks 2/4

Lipella Pharmaceuticals' CEO is Jon Kaufman, appointed in Jan 2005, has a tenure of 19.33 years. total yearly compensation is $323.38K, comprised of 63.1% salary and 36.9% bonuses, including company stock and options. directly owns 12.63% of the company’s shares, worth $720.22K. The average tenure of the management team and the board of directors is 16.8 years and 2.2 years respectively.

Key information

Jon Kaufman

Chief executive officer

US$323.4k

Total compensation

CEO salary percentage63.1%
CEO tenure19.3yrs
CEO ownership12.6%
Management average tenure16.8yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jon Kaufman's remuneration changed compared to Lipella Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$323kUS$204k

-US$5m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

-US$3m

Dec 31 2022US$183kUS$183k

-US$3m

Sep 30 2022n/an/a

-US$3m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$914kUS$183k

-US$2m

Dec 31 2020US$183kUS$183k

-US$62k

Compensation vs Market: Jon's total compensation ($USD323.38K) is below average for companies of similar size in the US market ($USD661.15K).

Compensation vs Earnings: Jon's compensation has increased whilst the company is unprofitable.


CEO

Jon Kaufman (56 yo)

19.3yrs

Tenure

US$323,383

Compensation

Dr. Jonathan Kaufman, also known as Jon, PhD, MBA, co-founded Lipella Pharmaceuticals Inc. in 2005 and serves as its President, Chief Executive Officer, Secretary and Treasurer and Chairman of the Board of...


Leadership Team

NamePositionTenureCompensationOwnership
Jonathan Kaufman
Co-Founder19.3yrsUS$323.38k12.63%
$ 720.2k
Michael Chancellor
Co-Founder19.3yrsUS$315.08k12.47%
$ 711.1k
Douglas Johnston
Chief Financial Officer1.5yrsUS$260.00k0%
$ 0
Michele Gruber
Director of Operations14.2yrsno data0%
$ 0
Katie Johnston
Controllerno datano datano data

16.8yrs

Average Tenure

56yo

Average Age

Experienced Management: LIPO's management team is seasoned and experienced (16.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jonathan Kaufman
Co-Founder19.3yrsUS$323.38k12.63%
$ 720.2k
Michael Chancellor
Co-Founder16.3yrsUS$315.08k12.47%
$ 711.1k
William de Groat
Member of Advisory Boardno datano datano data
Roger Dmochowski
Member of Advisory Boardno datano datano data
Leaf Huang
Member of Advisory Boardno datano data7.89%
$ 450.2k
Ryan Pruchnic
Independent Director2.7yrsUS$62.50k0%
$ 0
Michael Brennan
Member of Scientific Advisory Board1.2yrsno datano data
Byong Kim
Independent Director2.2yrsUS$63.30k0%
$ 0
Naoki Yoshimura
Independent Director & Member of Advisory Board2.7yrsUS$62.50k0%
$ 0
Alessandro Villa
Chair of the Scientific Advisory Board1.2yrsno datano data
Kamal Al-Eryani
Member of Scientific Advisory Board1.2yrsno datano data
Vidya Sankar
Member of Scientific Advisory Board1.2yrsno datano data

2.2yrs

Average Tenure

56yo

Average Age

Experienced Board: LIPO's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.